Publications by authors named "E Cano-Jimenez"
Background: Idiopathic pulmonary fibrosis (IPF) is a fatal progressive lung disease entailing significant impairment in health-related quality of life (HRQoL) and high socioeconomic burden. The course of IPF includes episodes of acute exacerbations (AE-IPF) leading to poor outcomes. This study aimed to compare management, costs and HRQoL of patients with AE-IPF to patients without AE-IPF during one year in Spain.
View Article and Find Full Text PDF[Influence of Clinical Practice Guidelines on the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis. Data from the Registry of the Spanish Society of Pulmonology and Thoracic Surgery].
Open Respir Arch
May 2024
Article Synopsis
- The study aimed to evaluate how the diagnostic process and time to treatment for idiopathic pulmonary fibrosis (IPF) patients changed from 2011 to 2019, in relation to updates in clinical practice guidelines.
- A total of 929 out of 1064 patients from a registry were analyzed, revealing that diagnosis methods evolved over time, with a shift from surgical biopsies to non-invasive imaging like chest CT scans.
- Key findings showed that the average time from symptom onset to diagnosis was 360 days, and many patients experienced delays in receiving antifibrotic treatment, indicating a need for improved diagnostic efficiency.
Background: Fibrotic hypersensitivity pneumonitis (fHP) is an immune-mediated interstitial lung disease caused by sensitisation to chronic allergen inhalation. This study aimed to determine prognostic indicators of progression and mortality in fHP.
Methods: This was a retrospective, multicentre, observational, cross-sectional cohort study of consecutive patients diagnosed with fHP from 1 January 2012 to 31 December 2021.
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease associated with dyspnoea, cough and impaired quality of life affecting around 7500 patients in Spain.
Objective: Our aim was to estimate the economic impact of IPF according to forced vital capacity (FVC) % predicted level in adult patients.
Methods: We conducted a prospective, observational, multicentric study of patients with confirmed IPF in Spain.
SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis.
Reumatol Clin (Engl Ed)
October 2022
Objective: To develop multidisciplinary recommendations to improve the management of rheumatoid arthritis-related interstitial lung disease (RA-ILD).
Methods: Clinical research questions relevant to the objective of the document were identified by a panel of rheumatologists and pneumologists selected based on their experience in the field. Systematic reviews of the available evidence were conducted, and evidence was graded according to the Scottish Intercollegiate Guidelines Network (SIGN) criteria.